Bottom line
Is ASCE a good fund? The bottom line
ASCE is a managed small-cap ETF from Allspring.
Annual fees run 0.38% — about $38 a year on every $10,000 invested, cheaper than 91% of small-cap funds we track.
With $118 million in net assets and 56 holdings, its largest position is Carpenter Technology Corp (3.1%) and the top 10 make up 26% of the portfolio.
What stands out
- Low cost: cheaper than 91% of small-cap peers
Updated Nov 19, 2026
What ASCE invests in
The Fund seeks long-term capital appreciation.
Under normal circumstances, we invest: at least 80% of the Funds net assets plus borrowing for investment purposes in equity securities of small- and medium-capitalization U.S. companies; and up to 20% of the Funds total assets in equity securities of foreign issuers in developed markets including through American depositary receipts (ADRs) and similar investments. The Fund invests principally in equity securities of small and mid-sized U.S. companies, which are defined as companies with market capitalizations within the range of the Russell 2500 Index at the time of purchase. The market capitalization range of the Russell 2500 Index was approximately $1 million to $58.5 billion, as of May 31, 2025, and is expected to change frequently. We may also invest in equity securities of foreign issuers in developed markets including ADRs and similar investments. Generally, we avoid investments…
From the fund's prospectus (filed Jan 23, 2026).
What ASCE costs
On a $10,000 investment, ASCE's 0.38% expense ratio costs about $38 a year. The prospectus estimates $480 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
ASCE top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Carpenter Technology Corp | 3.07% |
| 2 | Credo Technology Group Holding Ltd | 3.05% |
| 3 | Onto Innovation Inc | 2.72% |
| 4 | TTM Technologies Inc | 2.68% |
| 5 | Blue Bird Corp | 2.62% |
| 6 | Corcept Therapeutics Inc | 2.51% |
| 7 | StoneX Group Inc | 2.44% |
| 8 | Amneal Pharmaceuticals Inc | 2.44% |
| 9 | Bel Fuse Inc | 2.24% |
| 10 | Exelixis Inc | 2.22% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 26% of the fund. See all top 25 holdings and asset mix →